LeMaitre Vascular Inc LMAT
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Trading Information
- Previous Close Price
- $79.29
- Day Range
- $77.46–79.76
- 52-Week Range
- $77.46–118.01
- Bid/Ask
- $75.01 / $84.95
- Shares Outstanding
- 22.88M
- Market Cap
- $1.78B
- Volume/Avg
- 166,323 / 290,211
Key Statistics
- Price/Earnings (Normalized)
- 27.25
- Price/Sales
- 6.64
- Dividend Yield (Trailing)
- 1.22%
- Dividend Yield (Forward)
- 1.29%
- Dividend Payment Schedule
- Mar, Jun, Sep, Dec
- Total Yield
- 1.22%
Company Profile
LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Small Growth
- Total Number of Employees
- 655
- Website
- https://www.lemaitre.com
Competitors
Valuation
Metric | LMAT | BSX | MDT |
|---|---|---|---|
Price/Earnings (Normalized) | 27.25 | 13.86 | 17.84 |
Price/Book Value | 4.11 | 2.50 | 2.57 |
Price/Sales | 6.64 | 3.10 | 3.46 |
Price/Cash Flow | 19.81 | 13.03 | 14.49 |
Price/Earnings
LMAT
BSX
MDT
Financial Strength
Metric | LMAT | BSX | MDT |
|---|---|---|---|
Quick Ratio | 12.29 | 0.62 | 1.29 |
Current Ratio | 14.60 | 1.36 | 2.07 |
Interest Coverage | 16.73 | 10.67 | 10.12 |
Quick Ratio
LMAT
BSX
MDT
Profitability
Metric | LMAT | BSX | MDT |
|---|---|---|---|
Return on Assets (Normalized) | 11.53% | 10.68% | 8.31% |
Return on Equity (Normalized) | 17.81% | 19.06% | 15.59% |
Return on Invested Capital (Normalized) | 12.86% | 13.72% | 10.57% |
Return on Assets
LMAT
BSX
MDT
Medical Instruments & Supplies Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Intuitive Surgical Inc ISRG | LOCK|T%&z^#s& | LOCK|^!d | $152B | |||
| Becton Dickinson & Co BDX | LOCK|C< | LOCK|>lJM@ | $59B | |||
| Medline Inc Ordinary Shares - Class A MDLN | LOCK|v??T>Z | LOCK|Sfd? | $35B | |||
| Alcon Inc ALC | LOCK|NNc$&#% | LOCK|JH%>l | $35B | |||
| ResMed Inc RMD | LOCK|@bd<?%Ht | LOCK|BCps | $34B | |||
| West Pharmaceutical Services Inc WST | LOCK|%S$^nWr# | LOCK|MBv | $29B | |||
| Solventum Corp SOLV | LOCK|#lDrMRd | LOCK|R& | $15B | |||
| Baxter International Inc BAX | LOCK|j@& | LOCK|B^RV | $13B | |||
| The Cooper Companies Inc COO | LOCK|>#^v#! | LOCK|#TP^ | $12B | |||
| Align Technology Inc ALGN | LOCK|!H!$#< | LOCK|&#n&N | $12B |
United States